Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.46 |
| ▸ | TDO2 | P48775 | 1/20 | 0.46 |
| ▸ | CCKBR | P32239 | 2/20 | 0.35 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | TACR1 | P25103 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL247407 | 0.87 | IDO1 (0.55) | IDO1TDO2CCKBRAKT1TACR1 | |
| SCHEMBL247406 | 0.87 | IDO1 (0.55) | IDO1TDO2CCKBRAKT1TACR1 | |
| SCHEMBL14619153 | 0.74 | IDO1 (0.46) | IDO1TDO2CCKBR | |
| SCHEMBL2605810 | 0.74 | CCKBR (0.41) | IDO1TDO2CCKBRAKT1TACR1 | |
| SCHEMBL12680063 | 0.73 | IDO1 (0.39) | IDO1TDO2CCKBRAKT1TACR1 | |
| SCHEMBL13188042 | 0.72 | IDO1 (0.41) | IDO1TDO2AKT1TACR1 | |
| SCHEMBL6860568 | 0.72 | IDO1 (0.41) | IDO1TDO2AKT1TACR1 | |
| SCHEMBL23824580 | 0.71 | IDO1 (0.61) | IDO1TDO2TACR1 | |
| SCHEMBL30310627 | 0.71 | IDO1 (0.61) | IDO1TDO2TACR1 | |
| SCHEMBL14129011 | 0.71 | AKT1 (0.37) | IDO1TDO2AKT1TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1575900-A4 | N-METHYL AMINO ACIDS | UBIQUITOUS TECHNOLOGIES PTY LT (AU) | 2007-02-21 | — | — | EP | disclosed |
| US-20050245432-A1 | N-methyl amino acids | UBIQUITOUS TECHNOLOGIES PTY. LTD. (AU) | 2005-11-03 | — | — | US | disclosed |
| EP-1575900-A1 | N-METHYL AMINO ACIDS | UBIQUITOUS TECHNOLOGIES PTY LTD (AU) | 2005-09-21 | — | — | EP | disclosed |
| WO-2004007427-A1 | N-METHYL AMINO ACIDS | UBIQUITOUS TECHNOLOGIES PTY LTD (AU) | 2004-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245432-A1 | N-methyl amino acids | VIP, NPPA, PTMS | IDO1 1489/4885TDO2 3235/4885CCKBR 54/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.